NCT07872306Phase 2Not yet recruiting

A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Study sponsor: Satellos Bioscience, Inc. · MSLE

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-12-30Estimated
Enrollment · participants51Estimated
Source updated2026-10-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.